How an issuer financing is structured and closed

An issuer financing runs in seven stages: scope, indicative structure, capacity and approvals, diligence, documentation, signing and funding, and then registration or the holding period. The order matters. Exchange capacity and the resale route are settled before the economics, because both of them change what the transaction can be.

Key takeaways

• Capacity is checked before price. How much can be issued without a shareholder vote, and at what price, is a listing-rule question. It sets the outside edge of the transaction.
• Disclosure runs on the issuer's timetable. A US reporting company generally files a Form 8-K within four business days of entering into a material definitive agreement. The issuer's counsel controls that filing.
• The resale clock starts at closing, not at signing. Registration effectiveness and the Rule 144 holding period both run from issuance, so the resale route is agreed in writing beforehand.
• Timing depends on third parties. Counsel, the transfer agent, the depository, the exchange and the regulator all sit on the critical path. No published timetable binds any of them.

The seven stages

The sequence is the same whether the transaction is a single subscription or a facility drawn over years. What changes is how much of it repeats.

1. Introduction and scope

   Send the exchange and ticker, the free float, average daily traded value, the shelf or prospectus position, any facility already in place, the issuance capacity remaining, and the use of proceeds. Nothing is signed at this stage.

2. Indicative structure

   We come back with an instrument, a size, a tenor and a pricing mechanic the float can absorb. Capacity rules are checked before the economics, because a structure needing a shareholder vote is a different transaction on a different timetable.

3. Capacity, approvals and the resale route

   Three questions are settled before terms are agreed: how much can be issued without a shareholder vote, whether the price trips a discount or minimum-price rule, and by which route the securities become resaleable. Counsel in the listing jurisdiction confirms each.

4. Diligence

   Cap table, disclosure record, transfer agent and registrar, existing convertibles and warrants, and any restriction on further issuance already signed. Diligence is proportionate to the size, and it runs both ways: ask what happens to our position after closing.

5. Documentation

   Counsel draft the subscription or note documents, the closing conditions, and any registration undertaking with its filing and effectiveness deadlines. Nothing binds either side until definitive documents are signed; an indicative structure is not a commitment.

6. Signing, disclosure and funding

   The agreement is signed, the issuer makes the disclosure its market requires on its own timetable, the closing conditions are satisfied, the securities are delivered, and the proceeds settle.

7. Registration, the holding period and drawdowns

   The resale clock starts at closing. Either a resale registration statement is filed and taken effective, or the Rule 144 holding period runs where Rule 144 is available. A facility then operates on the issuer's own drawdown notices.

Who does what, and what gates it

Most delay here is not commercial. It comes from a document that does not exist yet, or a third party nobody has asked.

What actually stops a financing

Five things account for most transactions that do not close. Four are visible in the first hour.

Capacity is already spent. An issuer that has used its placement capacity or general mandate cannot issue again without a meeting. The price trips a rule. A discount that looks ordinary can turn a routine issue into one requiring shareholder approval, which is the point of the Nasdaq minimum-price test and its equivalents elsewhere.

The disclosure record is not current. Where the resale route depends on current public information, a late filing suspends it. The securities cannot settle. A transfer restriction at the depository defeats the mechanics whatever the paperwork says, which is why DTC eligibility is checked early. The issuer has a shell history. Not fatal, but it changes the route entirely, because Rule 144 is unavailable to a current or former shell company except on the Rule 144(i) conditions.

Before you write

Read who we fund first: faster to rule yourself out in two minutes than in two calls. Then the instrument set, or equity facilities if the need is a work programme. Then send what stage one needs.

Primary sources

• Nasdaq Listing Rules — Rule 5635(d) and the Minimum Price
• U.S. Securities and Exchange Commission — Form 8-K requirements and the four-business-day deadline
• U.S. Securities and Exchange Commission — Revisions to Rules 144 and 145
• ASX Listing Rules — Chapter 7, changes in capital and new issues

Process: frequently asked questions

How long does an issuer financing take?

It depends on parties outside anyone's control: counsel on both sides, the transfer agent, the exchange, and whether a shareholder meeting is required. A transaction inside existing issuance capacity and off an effective shelf moves faster than one needing a vote or a new registration statement. We publish no timetable, because a timetable published in advance is a promise about third parties.

Does an issuer financing need shareholder approval?

Sometimes, and the answer is set by the listing venue, not the instrument. On Nasdaq, Listing Rule 5635(d) requires shareholder approval before a 20% Issuance priced below the Minimum Price. The ASX works from placement capacity in Listing Rule 7.1, and HKEX from the general mandate. Stage three answers this before terms are agreed.

What does the issuer have to produce?

A current cap table including all convertibles and warrants, the disclosure record, transfer agent and registrar details, board authority for the issue, any agreement that restricts further issuance, and a clear statement of the use of proceeds. Almost all of it already exists; assembling it before the first call is the largest thing an issuer controls.

When is the transaction announced?

On the issuer's own disclosure timetable, under its own rules. A US reporting company generally files a Form 8-K within four business days of entering into a material definitive agreement, and separately reports an unregistered sale of equity securities. The issuer and its counsel control that filing, not us.

What happens after closing?

Two things run in parallel. The resale route proceeds, which normally means filing a registration statement and taking it effective, or waiting out the Rule 144 holding period where Rule 144 is available. If the transaction is a facility, the issuer then decides when and whether to draw on it.